Advances in Cancer Immunotherapy™ (ACI) Committee

The Advances in Cancer Immunotherapy™ (ACI) Committee oversees the planning and implementation of SITC’s regional introductory, CME-, CNE- and CPE-certified programs created for the entire clinical cancer care team. The committee provides expert guidance to the appropriate audiences and timely content relevant to advancing patient care using FDA-approved immunotherapies.

Chair

Brian Rini, MD – Cleveland Clinic Taussig Cancer Center